Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Melanoma Stories

2013-10-29 23:19:45

Reportbuyer.com just published a new market research report: Global Melanoma Therapeutics Market 2012-2016. London (PRWEB) October 29, 2013 TechNavio analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the availability of new promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination...

2013-10-28 23:28:47

Chichester will administer non-invasive skin cancer treatment in the office using the new superficial radiation therapy (SRT) machine. Keller, Texas (PRWEB) October 28, 2013 Dermatology Alliance-Keller, an award-winning provider of medical and cosmetic dermatology services in Keller and North Fort Worth, hired Roseanne Chichester as its on-staff radiation therapist. In this role, Chichester will administer non-invasive skin cancer treatment in the office using the new superficial...

2013-10-28 16:24:40

BOULDER, Colo., Oct. 28, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2014 and hold a conference call to discuss those results on Thursday, October 31, 2013. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Conference Call Information Date:...

2013-10-22 23:25:13

Tournament players and sponsors will help make a difference in the fight against melanoma, while having the opportunity to mingle with some of their favorite celebrities and VIPs. Hollywood, CA (PRWEB) October 22, 2013 The Melanoma Research Foundation (MRF) announced that actor and comedian Kevin Nealon will reprise his role as host of the second annual Celebrity Golf Classic to fuel melanoma research on November 18th at the Lakeside Golf Club in Burbank, CA. Kevin is partnering with the...

2013-10-22 23:01:27

Los Angeles dermatologist and creator of the innovative anti aging RejuveMD Sunscreen, Dr. Alex Khadavi weighs in on the myths of sun exposure and how to protect yourself from the harmful rays. Los Angeles, CA (PRWEB) October 22, 2013 It's common knowledge today that sun exposure causes melanoma and other types of skin cancers. USA Today reported their "Five Tanning Myths Exposed" going into the winter months. Board certified Dermatologist and creator of anti aging line...

2013-10-22 12:25:09

More Than Three-Quarters of Non-Prescribers Anticipate Prescribing Tafinlar and Mekinist Within the Next Six Months, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 22, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that at one month post-launch, approximately one-quarter of surveyed U.S. medical oncologists have prescribed GlaxoSmithKline's BRAF-inhibitor...

2013-10-21 13:17:16

LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October...

2013-10-21 08:28:49

ALBANY, New York, October 21, 2013 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 ResearchMoz announces that it has published a new study Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global...

2013-10-15 08:31:16

IRVINGTON, N.Y., Oct. 15, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced that MelaFind® was featured on "The Rachael Ray Show," the Emmy award-winning national daytime talk show hosted by celebrity chef and best-selling author Rachael Ray....

Red Wine Compound Helps Kill Cancer Cells
2013-10-14 10:50:04

[ Watch the Video: Red Wine Scores More Health Points ] Brett Smith for redOrbit.com - Your Universe Online Previous research has linked red wine to numerous health benefits, and a new study from the University of Missouri has found that a compound in the beverage can be used to boost the effectiveness of radiation-based cancer therapy. In the study, the red-wine compound resveratrol was used to treat melanoma cells, resulting in 44 percent of the tumor cells being killed. When the...